Series B funding round for Viridian Therapeutics raising $20M in April 2012
Series B funding round for Viridian Therapeutics raising $20M in April 2012
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Corporate Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$89M
Top Valuation
-
Viridian Therapeutics raised $20M in a Series B round.
The round was announced on 04/01/12.
The round was led by John Creecy.